Virtus LifeSci Biotech Clinical Trials ETF
19 hedge funds and large institutions have $42.1M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.14% more ownership
Funds ownership: 50.58% → 54.72% (+4.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
19
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.69M | |
| 2 | +$542K | |
| 3 | +$464K | |
| 4 |
VF
Virtu Financial
New York
|
+$369K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$290K |